1. Home
  2. PNI vs CBUS Comparison

PNI vs CBUS Comparison

Compare PNI & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pimco New York Municipal Income Fund II of Beneficial Interest

PNI

Pimco New York Municipal Income Fund II of Beneficial Interest

HOLD

Current Price

$7.06

Market Cap

76.9M

Sector

Finance

ML Signal

HOLD

Logo Cibus Inc.

CBUS

Cibus Inc.

HOLD

Current Price

$1.90

Market Cap

69.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PNI
CBUS
Founded
2002
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Agricultural Chemicals
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
76.9M
69.9M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
PNI
CBUS
Price
$7.06
$1.90
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$20.00
AVG Volume (30 Days)
26.4K
261.7K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
4.76%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,794,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$109.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.03
$1.09
52 Week High
$7.89
$3.40

Technical Indicators

Market Signals
Indicator
PNI
CBUS
Relative Strength Index (RSI) 61.84 52.82
Support Level $6.97 $1.80
Resistance Level $7.08 $2.05
Average True Range (ATR) 0.06 0.23
MACD 0.01 -0.02
Stochastic Oscillator 82.76 31.31

Price Performance

Historical Comparison
PNI
CBUS

About PNI Pimco New York Municipal Income Fund II of Beneficial Interest

PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: